CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 148 enrolled
Drug / intervention
cholecalciferoldietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00524680
NCT00524680Phase 2Completed
CompareCT.gov

Study of Serum 25(OH) D3 Level Variability in Response to Different Doses of Oral Vitamin D Supplementation in Prostate Cancer Patients

Roswell Park Cancer Institute·interventional·Posted Sep 3, 2007·Updated Nov 2, 2015

In Brief

A Phase 2 clinical trial evaluating cholecalciferol for Prostate Cancer. Completed, enrolled 148 participants across 1 site.

Detailed Summary

RATIONALE: Vitamin D may be effective in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well 4 different doses of vitamin D works in treating patients with prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 3, 2007
Enrollment StartJun 1, 2007
Primary CompletionMay 1, 2011
Study CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 18.8 years ago

Interventions

cholecalciferoldietary

Given orally